Academic Department of HIV/GU Medicine, King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, London, UK.
J Int AIDS Soc. 2010 Aug 4;13:29. doi: 10.1186/1758-2652-13-29.
Long-term regular clinic follow up is an important component of HIV care. We determined the frequency and characteristics of HIV-infected patients lost to follow up from a London HIV clinic, and factors associated with loss to all HIV follow up in the UK.
We identified 1859 HIV-infected adults who had registered and attended a London clinic on one or more occasions between January 1997 and December 2005. Loss to follow up was defined as clinic non-attendance for one or more years. Through anonymized linkage with the Survey of Prevalent HIV Infections Diagnosed and Health Protection Scotland, national databases of all HIV patients in care in the UK up to December 2006, loss-to-follow-up patients were categorized as Transfers (subsequently received care at another UK HIV clinic) or UKLFU (no record of subsequent attendance at any HIV clinic in the UK). Logistic regression analysis was used to identify factors associated with UKLFU for those both on highly active antiretroviral therapy (HAART) and not on HAART.
In total, 722 (38.8%) of 1859 patients were defined as lost to follow up. Of these, 347 (48.1%) were Transfers and 375 (51.9%), or 20.2% of all patients, were UKLFU. Overall, 11.9% of all patients receiving HAART, and 32.2% not receiving HAART were UKLFU. Among those on HAART, risk factors for UKLFU were: African heterosexual female (OR = 2.22, 95% CI: 1.11-4.56) versus white men who have sex with men; earlier year of HIV clinic registration (1997-1999 OR: 3.51, 95% CI: 1.97-6.26; 2000-02 OR: 2.49, 95% CI: 1.43-4.32 vs. 2003-2005); CD4 count of < 200 versus > 350 cells/mm3 (OR = 1.99, 95% CI:1.05-3.74); and a detectable viral load of > 400 copies/ml (OR = 5.03, 95% CI: 2.95-8.57 vs. <or= 400 copies/ml) at last clinic visit.Among those not receiving HAART, factors were: African heterosexual male (OR = 3.91, 95% CI: 1.77-8.64) versus white men who have sex with men; earlier HIV clinic registration (2000-2002 OR: 2.91, 95% CI: 1.77-4.78; 1997-1999: OR: 5.26, 95% CI: 2.71-10.19); and a CD4 count of < 200 cells/mm3 (OR: 3.24, 95% CI: 1.49-7.04).
One in five HIV-infected patients (one in three not on HAART and one in nine on HAART) from a London clinic were lost to all clinical follow up in the UK. Black African ethnicity, earlier year of clinic registration and advanced immunological suppression were the most important predictors of UKLFU. There is a need for all HIV clinics to establish systems for monitoring and tracing loss-to-follow-up patients, and to implement strategies for improving retention in care.
长期定期的临床随访是艾滋病护理的重要组成部分。我们确定了从伦敦艾滋病毒诊所失去随访的艾滋病毒感染患者的频率和特征,并确定了与英国所有艾滋病毒随访失败相关的因素。
我们确定了 1859 名在 1997 年 1 月至 2005 年 12 月期间在伦敦诊所至少一次登记和就诊的艾滋病毒感染成年人。失访定义为一年或一年以上未到诊所就诊。通过与英国艾滋病毒感染者普遍感染和健康保护苏格兰调查的匿名链接,我们可以利用英国所有艾滋病毒感染者的国家数据库,直到 2006 年 12 月,失访患者分为转移(随后在英国另一家艾滋病毒诊所接受治疗)或英国 LFU(没有在英国任何艾滋病毒诊所随后就诊的记录)。逻辑回归分析用于确定在接受高效抗逆转录病毒治疗(HAART)和未接受 HAART 的患者中与英国 LFU 相关的因素。
共有 1859 名患者中的 722 名(38.8%)被定义为失访。其中,347 名(48.1%)为转移,375 名(51.9%)或所有患者的 20.2%为英国 LFU。总的来说,所有接受 HAART 的患者中有 11.9%,而未接受 HAART 的患者中有 32.2%为英国 LFU。在接受 HAART 的患者中,英国 LFU 的危险因素包括:非洲异性恋女性(OR=2.22,95%CI:1.11-4.56)与白人男性与男性发生性关系;HIV 诊所登记的较早年份(1997-1999 年 OR:3.51,95%CI:1.97-6.26;2000-02 年 OR:2.49,95%CI:1.43-4.32 与 2003-2005 年相比);CD4 计数<200 与>350 细胞/mm3(OR=1.99,95%CI:1.05-3.74);最后一次就诊时病毒载量可检测到>400 拷贝/ml(OR=5.03,95%CI:2.95-8.57 与 <或=400 拷贝/ml)。在未接受 HAART 的患者中,危险因素包括:非洲异性恋男性(OR=3.91,95%CI:1.77-8.64)与白人男性与男性发生性关系;HIV 诊所登记的较早年份(2000-2002 年 OR:2.91,95%CI:1.77-4.78;1997-1999 年 OR:5.26,95%CI:2.71-10.19);和 CD4 计数<200 细胞/mm3(OR:3.24,95%CI:1.49-7.04)。
从伦敦诊所获得的五分之一艾滋病毒感染患者(三分之一未接受 HAART 和九分之一接受 HAART)在英国所有临床随访中丢失。黑非洲种族、较早的诊所登记年份和免疫抑制的进展是英国 LFU 的最重要预测因素。所有艾滋病毒诊所都需要建立监测和追踪失访患者的系统,并实施改善护理保留的策略。